You are viewing an incomplete version of our website. Please click to reload the website as full version.

BARD1 antibody (BRCA1 Associated RING Domain 1) (AA 658-758)

Details for Product anti-BARD1 Antibody No. ABIN395260, Supplier: Log in to see
Antigen
  • BARD1
  • ENSMUSG00000060893
  • ENSMUSG00000073653
  • LOC100147913
Alternatives
anti-Human BARD1 antibody for Immunoprecipitation
Epitope
AA 658-758
23
16
13
6
3
2
2
1
1
1
1
1
1
Reactivity
Human
82
17
17
Host
Mouse
73
9
Clonality (Clone)
Monoclonal ()
Conjugate
This BARD1 antibody is un-conjugated
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
Application
ELISA
55
32
13
11
11
10
4
4
2
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen BARD1 (NP_000456, 658 a.a. ~ 758 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 K
Clone 2A11
Isotype IgG2a kappa
Specificity BARD1 (NP_000456, 658 a.a. ~ 758 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Purification This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Alternative Name BARD1 (BARD1 Antibody Abstract)
Background Synonyms: Serine protease inhibitor J6, 47 kDa heat shock protein, Collagen-binding protein, Colligin, Serpin H1,Hsp47, Cbp1, Serpinh1
Molecular Weight 86648 DA
Gene ID 12406
NCBI Accession NP_000456
Research Area Cancer, Cell Structure
Pathways DNA Damage Repair
Application Notes ELISA ~~ 1ug/ml~3ng/ml
Comment

Background: This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer.

Restrictions For Research Use only
Buffer PBS with 0.09% (w/v) sodium azide.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Supplier Images
ELISA image for anti-BARD1 antibody (BRCA1 Associated RING Domain 1) (AA 658-758) (ABIN395260) Detection limit for recombinant GST tagged BARD1 is approximately 3 ng/mL as a captur...
Background publications Liu, Wu, Chen, Ter-Minassian, Asomaning, Zhai, Wang, Su, Heist, Kulke, Lin, Liu, Christiani: "A Large-scale genetic association study of esophageal adenocarcinoma risk." in: Carcinogenesis, Vol. 31, Issue 7, pp. 1259-63, 2010 (PubMed).

Rose, Behm, Drgon, Johnson, Uhl: "Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score." in: Molecular medicine (Cambridge, Mass.), Vol. 16, Issue 7-8, pp. 247-53, 2010 (PubMed).

Harte, OBrien, Ryan, Gorski, Savage, Crawford, Mullan, Harkin: "BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription." in: Cancer research, Vol. 70, Issue 6, pp. 2538-47, 2010 (PubMed).

De Brakeleer, De Grève, Loris, Janin, Lissens, Sermijn, Teugels: "Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families." in: Human mutation, Vol. 31, Issue 3, pp. E1175-85, 2010 (PubMed).

Dizin, Irminger-Finger: "Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1." in: The international journal of biochemistry & cell biology, Vol. 42, Issue 5, pp. 693-700, 2010 (PubMed).